-
A Multicenter Randomized Double-Blind Placebo-Controlled 52-Week Maintenance and an Open-Label Extension Study of the Efficacy and Safety of Risankizumab in ...
The study will enroll subjects who have completed Study M16-067 or Study M16-065 and have achieved clinical response, defined as ...
Exact
Phase 
-
A Multicenter Randomized Double-Blind Placebo-Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Subjects with Moderately to ...
The trial will enroll subjects who have had an inadequate response (IR) to prior biologic therapy (bio-IR). The bio-IR population ...
Exact
Phase
-
Enteral Nutritional Therapy and the Gut Microbiota and their Metabolites in Ileostomy Contents (EMMI)
Are you between the ages of 18-70? Do you have an ileostomy? You may be eligible for this study!
Exact
-
A Phase 2 Multicenter Open-Label Extension Study to Evaluate the Safety and Tolerability of AK002 in Patients with Eosinophilic Gastritis ...
AK002 is a humanized non-fucosylated immunoglobulin G1 (IgG1) monoclonal antibody to the inhibitory receptor Siglec-8, present on mast cells, eosinophils ...
Exact
Phase 
-
An Open-Label Pilot Study of Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn’s Disease (Holiday)
You are being asked to take part in this research study because you have Crohn’s disease and the medical ...
Exact
-
Quality Improvement Assessment for Patient-Centered Community Health Worker Intervention
The purpose of the IMPaCT Transitions program is to help low-income general medicine patients who have been cared for at ...
Exact
-
“The Shift Worker’s Microbiome”
We are looking for healthy males, age 40-59 years old, non-smoking un-medicated who work the "shift-work" schedule (>3 shifts per ...
Exact
-
A Phase 2 Multicenter, Open Label, Randomized Study of Two Titration Regimens of Oral CXA-10 in Subjects with Primary Focal ...
Primary FSGS is a progressive disease that causes the kidneys to scar, to leak protein into the urine and may ...
Exact
Phase
-
A Phase 1 Open-Label Study to Evaluate the Safety Tolerability and Activity of AK002 in Patients with Eosinophilic Gastritis and ...
This study is being done to see how safe the investigational new drug, AK002 is and how it affects your ...
Free text
Phase 
Showing - of trials